Loading company financials…
OTC MARKETS · Chemicals · CIK 0001413119
$0.081
+1.25% · delayed ~15 min
Last price from Oct 22, 2026
$84.5M market value
From Kraig Biocraft Laboratories, Inc.'s FY2025 10-K, filed Mar 30, 2026 · read the filing
Kraig Biocraft Laboratories makes industrial chemicals.
The filing does not provide enough evidence for a clear financial conclusion.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Significant financial weakness across most measures.
From Kraig Biocraft Laboratories, Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Cash
$673.3K → $1.8M
Capital spending
$4.2K → $5.4K
Operating income
-$3.1M → -$3.4M
Profit
-$3.4M → -$3.6M
Measured against FY2024, from the 10-K filed Mar 30, 2026
Improved: +165.9%
$673.3K to $1.8MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: +27.2%
$4.2K to $5.4KSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
$300.2K wider
How the latest move compares (quote delayed ~15 min), and what was published around it
KBLB rose 1.25% on the latest quote. The average Materials company tracked here moved −1.23%, and the S&P 500 −1.04%. That is 2.5 points above its sector and 2.3 points above the market.
No filing from KBLB and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 0.0% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
The essentials
Each answered from the filings, with the numbers behind it.
No. It lost $3.6M last year.
Not enough history has been reported to judge growth.
Yes. It owes more than it owns — only $0.24 in assets for every $1 of liabilities. Its operating profit does not cover its interest bill — -5.91x against the interest it owes.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it lost $3.6M and generated -$1.8M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Mar 30, 2026Filing for FY2025 | FY202410-K · Mar 28, 2025Filing for FY2024 | FY202310-K · Mar 28, 2025Filing for FY2023 | FY202210-K · Apr 1, 2024Filing for FY2022 | FY202110-K · Mar 16, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| Selling, general and administrative | $2.0M | $1.7M | $1.5M | $825.5K | $1.5M | +12.1% |
| Operating income | -$3.4M | -$3.1M | -$2.6M | -$2.1M | -$2.8M | −9.8% |
| Interest expense | $570.7K | $529.6K | $484.7K | $154.0K | $238.1K | +7.8% |
| Income before tax | -$3.6M | -$3.4M | -$3.0M | -$3.8M | -$8.0M | −6.6% |
| Net income | -$3.6M | -$3.4M | -$3.0M | -$3.8M | -$8.0M | −6.6% |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $-0.003475 | $-0.003273 | $-0.002932 | $-0.00404 | $-0.009417 | −6.2% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Nothing recent
No insider trades, pending-sale notices or 5% stake filings from KBLB in the last few months. That is the ordinary case, not a gap.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Cash +331.8% · Profit $183.4K wider · Earnings per share $0.00 wider — against Q2 FY2025
Read the filingQuarterly report for Q1 FY2026
Operating income $245.0K wider · Profit $342.7K wider · Earnings per share $0.00 wider — against Q1 FY2025
Read the filingWrite down why you are following Kraig Biocraft Laboratories, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Kraig Biocraft Laboratories to Present Spider Silk Commercialization Strategy at International Silk Congress
Yahoo ·
Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets
Yahoo ·
Kraig Biocraft Laboratories Seeks Production Expansion as Spider Silk Output Reaches New Records
Yahoo ·
Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth
Yahoo ·
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from KBLB's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Mar 30, 2026), reported under the US GAAP taxonomy. View the source filing.
2 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Growth and Accounting had too few reported figures and are left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 6 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 2.0 | 3/6 | 10-K, filed Mar 30, 2026 |
| FY2024 | 2.0 | 2/6 | 10-K, filed Mar 28, 2025 |
| FY2023 | 2.0 | 2/6 | 10-K, filed Apr 1, 2024 |
| FY2022 | 2.0 | 3/6 | 10-K, filed Mar 29, 2023 |
| FY2021 | 2.0 | 3/6 | 10-K, filed Mar 16, 2022 |
| FY2020 | 2.0 | 3/6 | 10-K, filed Mar 12, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
3 of 6 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 3 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
-$3.1M to -$3.4MNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: $224.4K wider
-$3.4M to -$3.6MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: $49.0K narrower
-$1.8M to -$1.8MNotable
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Deteriorated: $0.00 wider
-$0.00 to -$0.00Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 13, 2026 — read it.
Improved: +331.8%
$785.5K to $3.4MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: $183.4K wider
-$726.1K to -$909.5KSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: $0.00 wider
-$0.00 to -$0.00Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: +6.0%
1.05B to 1.11BSignificant
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Deteriorated: $65.7K wider
-$637.7K to -$703.4KNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 13, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +17.3%
$2.9M to $3.4MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: $122.1K narrower
-$825.5K to -$703.4KNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: $33.2K narrower
-$942.7K to -$909.5KNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: $0.00 narrower
-$0.00 to -$0.00Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: +1.8%
1.09B to 1.11BNotable
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Trailing P/E is not meaningful because the latest trailing earnings are zero or negative. The price-to-book and price-to-sales figures below still provide reference points.
This company has not reported enough of the required figures to calculate this score.
Annual report for FY2025
Cash +165.9% · Capital spending +27.2% · Operating income $300.2K wider — against FY2024
Read the filingReported another event
Read the filingQuarterly report for Q3 FY2025
Operating income $1.0M wider · Profit $1.1M wider · Earnings per share $0.00 wider — against Q3 FY2024
Read the filingQuarterly report for Q2 FY2025
Operating income $848.4K narrower · Profit $880.1K narrower · Earnings per share $0.00 narrower — against Q2 FY2024
Read the filingQuarterly report for Q1 FY2025
Cash -80.6% · Operating income $131.8K wider · Profit $92.2K wider — against Q1 FY2024
Read the filingAnnual report for FY2024
Free cash flow $592.4K wider · Cash -73.6% · Operating income $459.8K wider — against FY2023
Read the filingRegistration statement for an offering of securities
Read the filingRegistration statement for an offering of securities
Read the filingRegistration statement for an offering of securities
Read the filingSigned a material agreement · Sold shares outside a public offering · Made a Regulation FD disclosure
Read the filingRegistration statement for an offering of securities
Read the filingQuarterly report for Q3 FY2024
Read the filingQuarterly report for Q2 FY2024
Read the filingQuarterly report for Q1 FY2024
Read the filingAnnual report for FY2023
Operating income $493.5K wider · Profit $812.2K narrower · Free cash flow $641.3K narrower — against FY2022
Read the filingSold shares outside a public offering
Read the filingRegistration statement for an offering of securities
Read the filingQuarterly report on Form 10-Q
Read the filingIndistinguishable From Magic: How Kraig Labs Brought Spider Silk into Reality
Yahoo ·
Primary sources and further research